Sign In
Buy MD
$21.84
+0.0800 (+0.368%)
At Close: Jun 03, 2026
Pediatrix Medical Group Reports Fourth Quarter Results
06:00am, Tuesday, 20'th Feb 2024
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Fourth Quarter Results.
Will High Expenses Ail Pediatrix Medical's (MD) Q4 Earnings?
01:16pm, Thursday, 15'th Feb 2024
Pediatrix Medical's (MD) Q4 results are likely to be hurt by an increase in practice salaries and benefits expense as well as softer patient volumes, partly offset by same-unit pricing growth.
Pediatrix Medical Group 2023 Fourth Quarter Conference Call/Webcast Scheduled for Tuesday, February 20, 2024
06:45am, Wednesday, 07'th Feb 2024
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2023 Fourth Quarter Conference Call/Webcast Scheduled for Tuesday, February 20, 2024.
Top 5 Health Care Stocks That Could Blast Off In December - DBV Technologies (NASDAQ:DBVT), Cigna Group (NYSE:CI)
10:47am, Friday, 01'st Dec 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
November is Prematurity Awareness Month, Announcement Comes in Celebration of World Prematurity Day on Friday, Nov. 17 LONG BEACH, Calif. , Nov. 16, 2023 /PRNewswire/ -- MemorialCare Miller Children'
Pediatrix (MD) Q3 Earnings Miss on High Costs, Shares Down 12%
03:47pm, Monday, 06'th Nov 2023
Pediatrix's (MD) third-quarter results suffer from the decline in same-unit revenues attributable to patient volume. Management currently expects 2023 adjusted EBITDA to be within $200-$210 million.
Pediatrix Medical Group, Inc. (MD) Q3 2023 Earnings Call Transcript
12:34am, Sunday, 05'th Nov 2023
Pediatrix Medical Group, Inc. (NYSE:MD ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance and Strategy Dr. Jim Swift - C
Pediatrix Medical Group (MD) Lags Q3 Earnings and Revenue Estimates
08:16am, Thursday, 02'nd Nov 2023
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.40 per share a year ago.
Pediatrix Medical Group Reports Third Quarter Results
06:00am, Thursday, 02'nd Nov 2023
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results.
Pediatrix Medical Group (MD) Reports Next Week: Wall Street Expects Earnings Growth
11:19am, Thursday, 26'th Oct 2023
Pediatrix Medical Group (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pediatrix Medical Group 2023 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 2, 2023
06:45am, Friday, 20'th Oct 2023
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, November 2, 2023 at 9:00 a.m. ET to discuss resu
MD or DOCS: Which Is the Better Value Stock Right Now?
12:46pm, Tuesday, 03'rd Oct 2023
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Doximity (DOCS). But which of these two stocks presents investors with the better va
Pediatrix Medical Group, Inc. (MD) Q2 2023 Earnings Call Transcript
08:49am, Sunday, 06'th Aug 2023
Start Time: 09:00 January 1, 0000 9:26 AM ET Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2023 Earnings Conference Call August 03, 2023, 09:00 AM ET Company Participants Jim Swift - CEO Marc Richards -
Pediatrix Medical Group (MD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
04:33pm, Friday, 04'th Aug 2023
The headline numbers for Pediatrix Medical Group (MD) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall St
Pediatrix (MD) Q2 Earnings Meet Estimates, Revenues Up Y/Y
03:00pm, Thursday, 03'rd Aug 2023
Pediatrix (MD) reiterates adjusted EBITDA guidance in the range of $235-$245 million for 2023 compared with $241 million in 2022.
